-
Childhood Cancer Data Initiative (CCDI): Pediatric In Vivo Testing Program –Sarcoma, Kidney, and Liver Cancers
Study
phs003160
-
Microbiomic and immunogenic biomarkers of adjuvant chemotherapy efficacy in stage III colorectal cancer
Study
JGAS000875
-
Hematopoietic Tet2 inactivation enhances the response to checkpoint blockade immunotherapy
Study
EGAS50000001191
-
Efficacy of two different FGFR-inhibitors in a patient with extrahepatic cholangiocarcinoma harboring an FGFR2 mutation
Study
EGAS50000000015
-
Drug Development against Tumor Microtube Networks in Glioblastoma
Study
EGAS50000000477
-
Whole genome, exome and transcriptome analysis to guide individualized cancer interpretation
Study
EGAS00001004013
-
Spatiotemporal Genomic Profiling of Intestinal Metaplasia Reveals Clonal Dynamics of Gastric Cancer Progression
Study
EGAS00001007067
-
Comprehensive genomic profiles of small cell lung cancer
Study
EGAS00001000925
-
Clinical outcomes and immune correlates of response to nivolumab plus chemoradiotherapy in women with locally-advanced cervical cancer – NiCOL study
Study
EGAS00001007297
-
Genetic Factors associated with Conversion from Active Surveillance to Treatment for Prostate Cancer
Study
phs002056
-
comprehensive genetic analysis and database construction for head and neck cancer
Study
JGAS000214
-
SDR-seq_06_BCL
Study
EGAS50000000374
-
Whole-exome sequencing (WES) analysis of untreated head and neck cancer patient-derived xenografts (PDXs) matched patient tumor tissue and normal mucosa tissue.
Study
EGAS50000001622
-
Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: Primary phase 2 trial results with ctDNA residual disease analyses
Study
EGAS50000001195
-
Non-coding mutations drive persistence of a founder pre-leukemic clone which initiates late relapse in T-ALL
Study
EGAS50000000129
-
Pan-cancer MSI and Lynch syndrome
Study
EGAS00001008405
-
Radiotherapy_induced_Sarcoma_exome
Study
EGAS00001000194
-
RNA sequencing of untreated head and neck cancer patient-derived xenografts (PDXs) and matched patient tumor tissue.
Study
EGAS50000001595
-
Exomes of High-risk Prostate cancer
Study
EGAS00001001015
-
Radiotherapy_induced_sarcoma
Study
EGAS00001000138
-
EORTC RP1335 SPECTA Lung cancer data
Study
EGAS00001004485
-
V2_panel_bait_design_test
Study
EGAS00001001780
-
ENU_HT_29_BRAF_Triple_Therapy_Clones
Study
EGAS00001001778
-
Glioblastoma_CRISPR_Screen
Study
EGAS00001001519
-
Signatures of mismatch repair deficiency in cancer genomes
Study
EGAS00001000182